You just read:

ViaCyte, Inc. raises $10.6 Million in a Private Financing to Support Clinical Development of its Cell Therapy Product for Insulin Dependent Diabetes

News provided by

ViaCyte, Inc.

Jul 10, 2013, 06:00 ET